+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The novel competitive n methyl d aspartate nmda antagonist cgp 37849 preferentially induces phencyclidine like behavioral effects in kindled rats attenuation by manipulation of dopamine alpha 1 and serotonin 1a receptors



The novel competitive n methyl d aspartate nmda antagonist cgp 37849 preferentially induces phencyclidine like behavioral effects in kindled rats attenuation by manipulation of dopamine alpha 1 and serotonin 1a receptors



Journal of Pharmacology and Experimental Therapeutics 257(3): 1146-1153



The novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 37849) was found to produce a phencyclidine (PCP)-like behavioral syndrome (ataxia, locomotion, stereotypies) in amygdala-kindled rats, whereas the amphetamine like behavioral alterations of the syndrome (locomotion, stereotypies) were only infrequently seen in nonkindled rats. In dose-response experiments in kindled and nonkindled rats, behavioral effects were scored using a ranked intensity scale, and the behaviors and behavioural scores determined after CGP 37849 were compared with those determined after i.p. administration of the noncompetitive NMDA receptor antagonist dizocilpine maleate (MK-801). In kindled rats, 20 mg/kg of CGP 37849 produced about the same scores for hyperlocomotion and head weaving as 0.1 mg/kg of MK-801. Kindled rats exhibited higher behavioral scores than nonkindled rats, especially in the case of CGP 37849. The behavioral effects produced by CGP 37849 in kindled rats were almost indistinguishable from the PCP-like behavioral effects induced by MK-801, indicating that CGP 37849 indeed produces a PCP-like pattern of behavior in kindled rats. Hyperlocomotion and head weaving induced by CGP 37849 in kindled rats could be attenuated or totally prevented by pretreated with ipsapirone, a partial agonist/antagonist at postsynaptic 5-hydroxytryptamine (5-HT) receptors of the 5-HT1A subtype. Furthermore, these behavioural effects were attenuated or blocked by the dopamine antagonist haloperidol and the alpha-1 adrenoceptor antagonist, prazosin. The data demonstrate that kindling induces a hypersensitivity to PCP-like behavioral effects of competitive and noncompetitive NMDA receptor antagonists, which could relate to the recent finding of increased function of NMDA receptors following kindling. Because increased function of NMDA receptors has been described also in human epileptic tissue, the present data may suggest that epileptic patients are susceptible to central stimulant effects of NMDA receptor antagonists.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007919522

Download citation: RISBibTeXText

PMID: 1675288


Related references

Effects of phencyclidine pcp a non competitive and npc 12626 a competitive n methyl d aspartate antagonist on mesolimbic dopamine systems an electrophysiological and behavioral comparison. Society for Neuroscience Abstracts 15(2): 1096, 1989

Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats. European Journal of Pharmacology 234(2-3): 237-245, 1993

Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats. European Journal of Pharmacology 374(2): 175-187, 1999

Cgp 37849 characterization of a novel and potent competitive n methyl d aspartate nmda receptor antagonist. British Journal of Pharmacology 97(Suppl.): 582P, 1989

Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice. Arzneimittel-Forschung 48(12): 1121-1125, 1998

Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology 30(10): 1039-1046, 1991

The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats. European Journal of Pharmacology 136(1): 133-134, 1987

Cgp 37849 a competitive nmda receptor antagonist prevents the behavioral and neurodegenerative effects of tetanus toxin in rat hippocampus. Molecular Neuropharmacology 1(2): 45-52, 1991

The effects of N-methyl-D-aspartate and its competitive antagonist, 3- propyl-1-phosphonic acid , injected into caudate-putamen on kindled amygdaloid seizures in rats. Brain Research 728(2): 242-246, 1996

The effects of N-methyl-D-aspartate and its competitive antagonist, 3- propyl-1-phosphonic acid , injected into the caudate/putamen on kindled amygdaloid seizures in rats. Neurosciences 21(Suppl. 2): P29-P32, 1995

The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neuroscience Letters 128(2): 191-194, 1991

Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. European Journal of Pharmacology 353(2-3): 177-189, Y 24, 1998

Hemodynamic effects of iv injections of the non competitive n methyl d aspartate nmda receptor antagonist mk 801 in conscious rats. FASEB Journal 6(4): A1523, 1992

Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. Journal of Pharmacology and Experimental Therapeutics 265(3): 1055-1062, 1993

Ly 274614 an antagonist of n methyl d aspartate nmda receptors protects against amphetamine induced neurotoxicity toward striatal dopamine neurons in rats. Society for Neuroscience Abstracts 16(1): 799, 1990